Literature DB >> 22825556

Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.

Philip W Kantoff, Celestia S Higano, Eric J Small, James B Whitmore, Mark W Frohlich, Paul F Schellhammer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22825556     DOI： 10.1093/jnci/djs279

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  12 in total

1.  Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617.

Authors:  Hojjat Ahmadzadehfar; Simone Wegen; Anna Yordanova; Rolf Fimmers; Stefan Kürpig; Elisabeth Eppard; Xiao Wei; Carl Schlenkhoff; Stefan Hauser; Markus Essler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-09       Impact factor: 9.236

Review 2.  Landscape of Immunotherapy in Genitourinary Malignancies.

Authors:  Deepak Ravindranathan; Omar Alhalabi; Hind Rafei; Amishi Yogesh Shah; Mehmet Asim Bilen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Demystifying immunotherapy in prostate cancer: understanding current and future treatment strategies.

Authors:  Ravi A Madan; James L Gulley; Philip W Kantoff
Journal:  Cancer J       Date:  2013 Jan-Feb       Impact factor: 3.360

Review 4.  Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment.

Authors:  Mansi Saxena; Nina Bhardwaj
Journal:  Trends Cancer       Date:  2018-02

5.  Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.

Authors:  Xiaodong Wang; Lauren C Harshman; Wanling Xie; Mari Nakabayashi; Fangfang Qu; Mark M Pomerantz; Gwo-Shu Mary Lee; Philip W Kantoff
Journal:  J Clin Oncol       Date:  2015-12-14       Impact factor: 44.544

Review 6.  Dendritic cell vaccine therapy for colorectal cancer.

Authors:  Amanda L Wooster; Lydia H Girgis; Hayley Brazeale; Trevor S Anderson; Laurence M Wood; Devin B Lowe
Journal:  Pharmacol Res       Date:  2020-12-28       Impact factor: 7.658

Review 7.  Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy.

Authors:  Peter F Mulders; Maria De Santis; Thomas Powles; Karim Fizazi
Journal:  Cancer Immunol Immunother       Date:  2015-05-30       Impact factor: 6.968

Review 8.  Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy.

Authors:  Julie N Graff; Erin D Chamberlain
Journal:  Core Evid       Date:  2014-12-18

Review 9.  The Promise of Preventive Cancer Vaccines.

Authors:  Pier-Luigi Lollini; Federica Cavallo; Patrizia Nanni; Elena Quaglino
Journal:  Vaccines (Basel)       Date:  2015-06-17

10.  Skin Delivery of Clec4a Small Hairpin RNA Elicited an Effective Antitumor Response by Enhancing CD8+ Immunity In Vivo.

Authors:  Tzu-Yang Weng; Chia-Jung Li; Chung-Yen Li; Yu-Hsuan Hung; Meng-Chi Yen; Yu-Wei Chang; Yu-Hung Chen; Yi-Ling Chen; Hui-Ping Hsu; Jang-Yang Chang; Ming-Derg Lai
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.